To see the other types of publications on this topic, follow the link: Palliative treatment.

Journal articles on the topic 'Palliative treatment'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Palliative treatment.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Baka, Sofia, Paul Lorigan, and Nick Thatcher. "Palliative treatment." Hematology/Oncology Clinics of North America 18, no. 2 (2004): 417–32. http://dx.doi.org/10.1016/j.hoc.2003.12.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kępka, Lucyna. "Palliative Thoracic Radiotherapy in the Era of Modern Cancer Care for NSCLC." Cancers 16, no. 17 (2024): 3018. http://dx.doi.org/10.3390/cancers16173018.

Full text
Abstract:
Palliative thoracic radiotherapy provides rapid and effective symptom relief in approximately two-thirds of NSCLC patients treated. In patients with poor performance status, the degree of palliation appears unrelated to the radiation dose or fractionation schedule. Conversely, in patients with good performance status, higher radiation doses administered over longer periods have shown modest survival benefits. These findings stem from studies conducted before the advent of immunotherapy and targeted therapy in clinical practice. Currently, there are no large prospective studies specifically ded
APA, Harvard, Vancouver, ISO, and other styles
3

Bjordal, K. "Palliative medical treatment." Radiotherapy and Oncology 82 (February 2007): S16. http://dx.doi.org/10.1016/s0167-8140(07)80054-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kon, Alexander A., and Arthur R. Ablin. "It's not palliative care, it's palliative treatment." Lancet Oncology 10, no. 2 (2009): 106–7. http://dx.doi.org/10.1016/s1470-2045(09)70011-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Patell, Rushad, David Johnson Einstein, Jennifer Halleck, and Mary K. Buss. "Patient perceptions of treatment benefit in advanced cancer." Journal of Clinical Oncology 37, no. 15_suppl (2019): e23163-e23163. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e23163.

Full text
Abstract:
e23163 Background: Informed consent assumes accurate perceptions of potential benefits and risks of treatment, yet many patients receiving palliative cancer therapies misperceive the likelihood of cure. Our study aims to further explore patient perceptions of benefits and risks of palliative treatments and to examine this in the era of novel therapeutics. Methods: We surveyed patients with advanced solid cancers and their oncologists regarding benefits/risks of palliative therapies. We serially assessed patients’ perceptions of likelihood of tumor response, survival benefit, symptom palliation
APA, Harvard, Vancouver, ISO, and other styles
6

Mishreki, AP, E. Lim, P. Cranefield, S. Pascoe, S. Jackson, and DA Stell. "Low rate of active treatment of patients with hilar cholangiocarcinoma." Annals of The Royal College of Surgeons of England 95, no. 5 (2013): 349–52. http://dx.doi.org/10.1308/003588413x13629960046598.

Full text
Abstract:
Introduction The results of surgical resection and palliative chemotherapy use in hilar cholangiocarcinoma (HC) have been well publicised but the proportion of patients able to undergo these treatments and the comparative outcomes in a population of patients with HC are less well known. Methods Patients with HC were identified by review of all patients undergoing percutaneous cholangiography over a nine-year period (2002–2010) in a tertiary facility. The treatment undertaken and outcomes were recorded. Results Overall, 68 patients were identified (37 female) with a median age of 70 years. Fort
APA, Harvard, Vancouver, ISO, and other styles
7

Patell, Rushad, David Johnson Einstein, Jennifer Halleck, Laura Dodge, and Mary K. Buss. "Patient perceptions of treatment benefit in advanced cancer." Journal of Clinical Oncology 37, no. 31_suppl (2019): 25. http://dx.doi.org/10.1200/jco.2019.37.31_suppl.25.

Full text
Abstract:
25 Background: Informed consent assumes accurate perceptions of potential treatment benefits and risks, yet many patients receiving palliative cancer therapies misperceive the likelihood of cure. Patients’ understanding of treatment benefits/risks beyond cure is unknown. We aimed to further explore patient perceptions of benefits/risks of palliative treatment in the era of novel therapeutics. Methods: We surveyed patients with advanced solid cancers and their oncologists regarding benefits/risks of palliative therapies. We assessed perceived likelihood of tumor response, survival benefit, symp
APA, Harvard, Vancouver, ISO, and other styles
8

Porzsolt, F., and I. Tannock. "Goals of palliative cancer therapy." Journal of Clinical Oncology 11, no. 2 (1993): 378–81. http://dx.doi.org/10.1200/jco.1993.11.2.378.

Full text
Abstract:
The major conclusions of the Workshop on Goals of Palliative Cancer Therapy are as follows: 1. The goals of any cancer therapy should be stated explicitly. 2. If the goal of treatment is palliation, this should be documented according to one of the established and validated methods for assessment of quality of life. Several validated methods are available, and although imperfect, have been shown to give reliable information. 3. The use of simple measures of quality of life (eg, symptom checklists, pain assessment cards) should become routine in oncology practice. The act of introducing such me
APA, Harvard, Vancouver, ISO, and other styles
9

Jeba, Jenifer, Ansu Mary Thankachan, Annie Jacob, Ramu Kandasamy, and D. N. Susithra. "COVID-19 – Initial Lockdown: Implications on Cancer Treatment among Palliative Care Outpatients." Indian Journal of Palliative Care 28 (March 16, 2022): 3–6. http://dx.doi.org/10.25259/ijpc_314_20.

Full text
Abstract:
Objectives: The pandemic and the lockdown has challenged palliative care patients especially those on palliative oncological treatments. This study aims to understand the effect of COVID-19 and initial lockdown on palliative oncological treatments among palliative care patients. Materials and Methods: A retrospective chart review of patients who attended the palliative care outpatient clinic, between 21 April and 12 May 2020, was done. Sociodemographic and palliative oncological treatment details were reviewed. Results: Of the 107 patients included, 53.7% were between 40 and 60 years of age, a
APA, Harvard, Vancouver, ISO, and other styles
10

Revannasiddaiah, Swaroop, RajeevK Seam, Manish Gupta, Madhup Rastogi, ManojK Gupta, and Priyanka Thakur. "When palliative treatment achieves more than palliation: Instances of long-term survival after palliative radiotherapy." Indian Journal of Palliative Care 18, no. 2 (2012): 117. http://dx.doi.org/10.4103/0973-1075.100829.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Vuong, Brooke, Ahmed Dehal, Amanda N. Graff-Baker, et al. "Effect of palliative surgery, chemotherapy, and radiation in stage IV pancreatic cancer." Journal of Clinical Oncology 35, no. 15_suppl (2017): e15707-e15707. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e15707.

Full text
Abstract:
e15707 Background: Despite significant advances in multi-modality treatment for pancreatic adenocarcinoma (PC), prognosis for stage IV PC remains poor. While reducing suffering and optimizing quality of life are the primary goals of palliative therapies, these interventions may extend overall survival. We examined the impact on survival when aggressive palliative treatments including surgery, chemotherapy, or radiation were employed in end-of-life care. Methods: The 2004-2014 National Cancer Data Base (NCDB) was queried to identify patients with stage IV PC that did not undergo primary surgica
APA, Harvard, Vancouver, ISO, and other styles
12

Vuong, Brooke, Ahmed Dehal, Amanda Graff-Baker, et al. "Effect of palliative surgery, chemotherapy, and radiation in stage IV pancreatic cancer." Journal of Clinical Oncology 35, no. 31_suppl (2017): 233. http://dx.doi.org/10.1200/jco.2017.35.31_suppl.233.

Full text
Abstract:
233 Background: Despite significant advances in multi-modality treatment for pancreatic adenocarcinoma (PC), prognosis for stage IV PC remains poor. While reducing suffering and optimizing quality of life are the primary goals of palliative therapies, these interventions may extend overall survival. We examined the impact on survival when aggressive palliative treatments including surgery, chemotherapy, or radiation were employed in end-of-life care. Methods: The 2004-2014 National Cancer Data Base (NCDB) was queried to identify patients with stage IV PC that did not undergo primary surgical r
APA, Harvard, Vancouver, ISO, and other styles
13

Volpe, Bruce T. "Palliative treatment for stroke." Neurologic Clinics 19, no. 4 (2001): 903–20. http://dx.doi.org/10.1016/s0733-8619(05)70053-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Patell, Rushad, David Einstein, Eric Miller, Laura Dodge, Jennifer Halleck, and Mary Buss. "Patient Perceptions of Treatment Benefit and Toxicity in Advanced Cancer: A Prospective Cross-Sectional Study." JCO Oncology Practice 17, no. 2 (2021): e119-e129. http://dx.doi.org/10.1200/op.20.00517.

Full text
Abstract:
PURPOSE: Prior studies show that many patients receiving palliative cancer therapies misperceive likelihood of cure. Patients’ understanding of treatment benefits and risks beyond cure is unknown. We explore patient perceptions of palliative treatment in the novel therapeutic era. METHODS: We surveyed patients with advanced solid cancers and their oncologists regarding benefits and risks of palliative therapies. We assessed perceived likelihood of tumor response, survival benefit, symptom palliation, and side effects. We used generalized estimating equations to calculate least squares means of
APA, Harvard, Vancouver, ISO, and other styles
15

Fackrell, David Gareth, Muhammad Suhail Anwar, Indrajit Nalinika Fernando, Yvonne Doyle, and Ahmed El-Modir. "Palliative external-beam radiotherapy in recurrent ovarian carcinoma." Journal of Clinical Oncology 30, no. 15_suppl (2012): e15534-e15534. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e15534.

Full text
Abstract:
e15534 Background: Up to 80% of patients with advanced ovarian cancer will recur following first-line platinum based chemotherapy. Palliation of focal lesions is often needed to alleviate symptoms. Response rate to second and third-line chemotherapy remain disappointing. The study aim was to characterise the patient population referred for palliative radiotherapy for advanced and recurrent ovarian carcinoma and to assess the effectiveness of radiotherapy in this population. Methods: We retrospectively reviewed the medical records of 94 patients with advanced recurrent ovarian carcinoma referre
APA, Harvard, Vancouver, ISO, and other styles
16

Bernardo, Ma Jeanesse C., Mohd Firdaus Che Ani, Zhuang Chun, et al. "Laparoscopic Conversion Surgery After Three Years of Palliative Chemotherapy for Unresectable Advanced Gastric Cancer." Journal of Surgical Innovation and Education 1, no. 1 (2024): 26–27. http://dx.doi.org/10.69474/jsie.2024.00073.

Full text
Abstract:
Unresectable advanced gastric cancer remains a challenge in treatment, often requiring a multidisciplinary approach. Numerous studies have emphasized the role of palliative chemotherapy as the mainstay treatment for unresectable advanced gastric cancers. Some patients may still require conversion surgery to achieve survival gain and palliation. Several recent papers have shown the safety of laparoscopic gastrectomy after neoadjuvant chemotherapy for advanced gastric cancer. However, there is a difference between neoadjuvant chemotherapy and palliative chemotherapy in terms of the duration of c
APA, Harvard, Vancouver, ISO, and other styles
17

Bingham, Brian Stewart, Tomas Dvorak, Christopher G. Morris, and Anamaria R. Yeung. "Thirty-day mortality rate in oncology patients treated with palliative radiotherapy." Journal of Clinical Oncology 34, no. 26_suppl (2016): 172. http://dx.doi.org/10.1200/jco.2016.34.26_suppl.172.

Full text
Abstract:
172 Background: Thirty-day mortality is a well-established metric for surgical specialties, but there are limited data available for 30-day mortality after radiation therapy. Our aim was to specifically identify the 30-day mortality of patients treated with palliative radiotherapy for the purposes of establishing a baseline to improve upon. Methods: We retrospectively reviewed the medical records of all patients treated with external-beam radiotherapy (EBRT) from January 1, 2012, to December 31, 2012, who died within 30 days of their last delivered radiation fraction. Patient age, sex, primary
APA, Harvard, Vancouver, ISO, and other styles
18

Raunkiær, Mette, Jahan Shabnam, Kristoffer Marsaa, Geana Paula Kurita, Per Sjøgren, and Mai-Britt Guldin. "When and how to stop palliative antineoplastic treatment and to organise palliative care for patients with incurable cancer." International Journal of Palliative Nursing 29, no. 10 (2023): 499–506. http://dx.doi.org/10.12968/ijpn.2023.29.10.499.

Full text
Abstract:
Background: Improving the organisational aspects of the delivery of palliative care in order to support patients throughout their disease trajectory has received limited attention. Aim: To investigate the opportunities and barriers related to organising palliation for people with terminal cancer and their families. Methods: An explorative interview study was conducted among 31 nurses and three physicians concerning an intervention facilitating a fast transition from treatment at a cancer centre at a university hospital to palliation at home. A thematic analysis was conducted. Findings: This ar
APA, Harvard, Vancouver, ISO, and other styles
19

Suhag, Virender, B. S. Sunita, Pankaj Vats, Nilotpal Chakravarty, Mayuri Jain, and Rekha S. Vashisht. "Profile of patients undergoing palliative radiotherapy: A single-institute study from a tertiary care oncology center." South Asian Journal of Cancer 06, no. 04 (2017): 190–93. http://dx.doi.org/10.4103/sajc.sajc_149_17.

Full text
Abstract:
Abstract Background: Palliative radiotherapy (PRT) plays a significant role in the palliation of symptoms in patients with cancer and constitutes nearly 50% of the workload in different settings. Aims: The aim is to study patient-, disease-, and treatment-related characteristics in locoregionally advanced and metastatic malignancies meriting palliative management. Setting and Design: This was a retrospective observational study in a tertiary care government institute with academic and research potential. Methodology: The electronic medical records, medical documents, and radiotherapy (RT) trea
APA, Harvard, Vancouver, ISO, and other styles
20

Panmei, Ruby, Yumkhaibam Sobita Devi, Angom Ronibala Devi, Dorafiona Swer, Ningthoujam Dinita Devi, and Rahul Mahawar. "A comparative study on tumour response, intrathoracic symptom palliation and toxicities in locally advanced inoperable non-small cell lung cancer patients receiving palliative chemoradiation versus radiation alone." International Journal of Research in Medical Sciences 13, no. 6 (2025): 2446–56. https://doi.org/10.18203/2320-6012.ijrms20251633.

Full text
Abstract:
Background: Locally advanced unresectable non-small cell lung cancer (LA-NSCLC) is a key focus in research, as it presents significant treatment challenges, with low survival rates despite progress in radiotherapy and systemic therapies. This study compares two palliative regimen for LA-NSCLC, one with radiation alone the other arm as concurrent chemoradiation therapy (CCRT) with nab-paclitaxel. Methods: A Randomised Controlled Trial was conducted in the Department of Radiation Oncology, Regional Institute of Medical Sciences, Imphal from July 2022 to June 2024. Sample size of 96 was calculate
APA, Harvard, Vancouver, ISO, and other styles
21

Kucharska, Ewa, Aleksandra Kucharska, Aleksander Sieroń, Mariusz Nowakowski, and Karolina Sieroń. "PALLIATIVE TREATMENT – STILL UNSOLVED PROBLEM." Wiadomości Lekarskie 72, no. 6 (2019): 1165–69. http://dx.doi.org/10.36740/wlek201906101.

Full text
Abstract:
In a modern approach to palliative and hospice care, apart from pharmacological treatment, physio- and kinesiotherapy also play an important role. It affects the reduction of clinical symptoms, accompanying the basic disease and also significantly increase of the quality of life for palliative patients and their families. It becomes an inseparable element of treatment, both in outpatient care as well as in stationary care and home care. Thanks to modern forms of physio- and kinesiotherapy, it is possible to adapt therapeutic methods to the individual needs and clinical condition of the patient
APA, Harvard, Vancouver, ISO, and other styles
22

Chernus, N. Yu, S. V. Sidorov, E. V. Babayants, and S. E. Krasilnikov. "Legal support of palliative care for cancer patients." Siberian journal of oncology 18, no. 2 (2019): 65–69. http://dx.doi.org/10.21294/1814-4861-2019-18-2-65-69.

Full text
Abstract:
Background. According to the novel approach to the treatment of patients as persons, the phenomenon of palliation distinguishes modern medicine from the traditional medical paternalism. it means that medical science and practice go beyond physical health, when treatment methods aimed to improving the quality of patient’ life are widely used. man as a phenomenon of culture becomes something much more than his physical body.The purpose of the study was to analyze the palliative care legislation.Results. The palliative care was shown not to be a type of medical care, but it refers to the terms us
APA, Harvard, Vancouver, ISO, and other styles
23

Fu, Qinghui, Ying Chen, and Xiaohan Liu. "The Choice of Palliative Treatment for Biliary and Duodenal Obstruction in Patients With Unresectable Pancreatic Cancer: Is Surgery Bypass Better?" International Surgery 101, no. 1-2 (2016): 58–63. http://dx.doi.org/10.9738/intsurg-d-14-00247.1.

Full text
Abstract:
This study aimed to investigate the clinical significance of palliative operation for carcinoma of pancreas between bypass surgery and interventional therapy. Most patients with locally advanced pancreatic cancer cannot undergo resection and show obstructive jaundice at presentation. Methods of palliation in these patients comprise biliary stent or surgical bypass. We retrospectively analyzed the clinical data of 53 patients who underwent palliative treatment with incurable locally advanced pancreatic ductal adenocarcinoma. This retrospective study compared morbidity, mortality, hospital stay,
APA, Harvard, Vancouver, ISO, and other styles
24

Bierle, Rebecca (Schuetz), Karen M. Vuckovic, and Catherine J. Ryan. "Integrating Palliative Care Into Heart Failure Management." Critical Care Nurse 41, no. 3 (2021): e9-e18. http://dx.doi.org/10.4037/ccn2021877.

Full text
Abstract:
Background The World Health Organization defines palliative care as an approach that improves the quality of life of patients and their families through the prevention and relief of suffering by assessment and treatment of physical, psychosocial, and spiritual problems. Any patient with chronic debilitating disease, including heart failure, is a candidate for interdisciplinary palliative care to manage their complex physical and psychosocial needs. Clinical Relevance The philosophy of palliative care has evolved to include a vision of holistic care extended to all individuals with serious illn
APA, Harvard, Vancouver, ISO, and other styles
25

Wadiwala, Janvi, Mausam Patel, Chenghui Li, Sanjay Maraboyina, Ahmed Safar, and Thomas Kim. "Health care disparities and barriers to palliative care among metastatic renal cell carcinoma patients: An NCDB analysis." Journal of Clinical Oncology 39, no. 15_suppl (2021): 4545. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.4545.

Full text
Abstract:
4545 Background: Palliative care improves quality of life for both patients and caregivers but may be underutilized due to socioeconomic barriers to access. An NCDB analysis was performed to analyze the effect of socioeconomics on palliative care receipt among patients with metastatic renal cell carcinoma. Methods: A retrospective hospital-based analysis was performed using the National Cancer Database to identify variables that significantly affect receipt of palliative care among patients diagnosed with metastatic renal cell carcinoma diagnosed between 2004 and 2016. Sub-cohort analysis was
APA, Harvard, Vancouver, ISO, and other styles
26

Wilson, Ana, Cecilia Grace Ethun, George A. Poultsides, et al. "Palliative treatment in extrahepatic biliary malignancies: A multi-institutional cohort." Journal of Clinical Oncology 34, no. 4_suppl (2016): 456. http://dx.doi.org/10.1200/jco.2016.34.4_suppl.456.

Full text
Abstract:
456 Background: Extrahepatic biliary malignancies (EBM) are often first diagnosed at advanced stages when the disease is no longer surgically resectable. While palliative resection may provide a more definitive solution for patients with jaundice, it also carries a higher risk of complications than endoscopic or percutaneous drainage. Herein, we analysed patients undergoing both methods of palliation to better delineate these risks. Methods: 172 patients who underwent palliative treatment for EBM between 2000 and 2014 were identified from 10 major hepato-biliary centers participating in the EB
APA, Harvard, Vancouver, ISO, and other styles
27

Matoska, Thomas, Anjishnu Banerjee, Aditya Shreenivas, et al. "Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer." Cancers 15, no. 9 (2023): 2523. http://dx.doi.org/10.3390/cancers15092523.

Full text
Abstract:
Background: The study of oligometastatic esophageal cancer (EC) is relatively new. Preliminary data suggests that more aggressive treatment regimens in select patients may improve survival rates in oligometastatic EC. However, the consensus recommends palliative treatment. We hypothesized that oligometastatic esophageal cancer patients treated with a definitive approach (chemoradiotherapy [CRT]) would have improved overall survival (OS) compared to those treated with a purely palliative intent and historical controls. Methods: Patients diagnosed with synchronous oligometastatic (any histology,
APA, Harvard, Vancouver, ISO, and other styles
28

Öhlén, J., G. Carlsson, A. Jepsen, I. Lindberg, and F. Friberg. "Enabling sense-making for patients receiving outpatient palliative treatment: A participatory action research driven model for person-centered communication." Palliative and Supportive Care 14, no. 3 (2015): 212–24. http://dx.doi.org/10.1017/s1478951515000814.

Full text
Abstract:
ABSTRACTObjectives:In clinical palliative cancer care, the diversity of patient concerns over time makes information provision a critical issue, the demands of information-seeking patients presenting a challenge to both the communicative and organizational skills of the health provider. This study puts forward a practice model for communication between patients, their family members, and professional health providers during ongoing palliative chemotherapy; a model which supports the providers in enabling person-centered communication.Method:A constant comparative analysis adapted to participat
APA, Harvard, Vancouver, ISO, and other styles
29

Emby, D. J. "Palliative Treatment of Malignant Ascites." American Journal of Roentgenology 179, no. 2 (2002): 532. http://dx.doi.org/10.2214/ajr.179.2.1790532a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Unseld, Matthias. "Palliative treatment in daily practice." memo - Magazine of European Medical Oncology 14, no. 1 (2021): 5–6. http://dx.doi.org/10.1007/s12254-021-00682-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Nielsen, Ole S. "Palliative Treatment of Bone Metastases." Acta Oncologica 35, sup5 (1996): 58–60. http://dx.doi.org/10.3109/02841869609083971.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Ring, Alistair, and Peter Harper. "Palliative Treatment: What’s the Point?" American Journal of Clinical Oncology 25, no. 5 (2002): 537–39. http://dx.doi.org/10.1097/00000421-200210000-00024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

VON WICHERT, Götz, Thomas SEUFFERLEIN, and Guido ADLER. "Palliative treatment of pancreatic cancer." Journal of Digestive Diseases 9, no. 1 (2008): 1–7. http://dx.doi.org/10.1111/j.1443-9573.2007.00314.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Ahmad, Neelofur R., Eric B. Goosenberg, Harold Frucht, and Lawrence R. Coia. "Palliative treatment of esophageal cancer." Seminars in Radiation Oncology 4, no. 3 (1994): 202–14. http://dx.doi.org/10.1016/s1053-4296(05)80068-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Ring, Alistair, and Peter Harper. "Palliative Treatment: What’s the Point?" American Journal of Clinical Oncology 25, no. 5 (2002): 537–39. http://dx.doi.org/10.1097/01.coc.0000023420.56046.d3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Bengmark, S. "Palliative treatment of hepatic tumours." British Journal of Surgery 76, no. 8 (1989): 771–73. http://dx.doi.org/10.1002/bjs.1800760802.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Pohl, M., A. Reinacher-Schick, and W. Schmiegel. "Palliative endoscopic and chemotherapeutic treatment." European Surgery 42, no. 6 (2010): 287–98. http://dx.doi.org/10.1007/s10353-010-0571-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

McKinnon, J. Gregory. "Palliative treatment of neuroendocrine tumors." Seminars in Surgical Oncology 9, no. 5 (1993): 453–58. http://dx.doi.org/10.1002/ssu.2980090513.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Tseimakh, Alexander E., Alexander F. Lazarev, and Yakov N. Shoykhet. "Palliative treatment of pancreatic cancer." Russian Journal of Oncology 27, no. 3 (2023): 117–26. http://dx.doi.org/10.17816/onco115222.

Full text
Abstract:
Pancreatic cancer is one of the most serious problems of modern oncology. In the Russian Federation, pancreatic cancer, along with a fairly small share in the structure of the incidence of malignant neoplasms 3%, ranks first in annual mortality (68.2%), and is also a nosology with the most unfavorable prognosis among tumors of the gastrointestinal tract. The current standard of first-line therapy is FOLFRINOX (FOLFIRINOX, a combination of 5-fluorouracil (5-FU), leucovorin, irinotecan, and oxaliplatin) or gemcitabine plus albumin-bound nab-paclitaxel.
 One of the main obstacles to the acti
APA, Harvard, Vancouver, ISO, and other styles
40

Buiting, Hilde M., Mirian Brink, Marleen N. Wijnhoven, et al. "Doctors’ reports about palliative systemic treatment: A medical record study." Palliative Medicine 31, no. 3 (2016): 239–46. http://dx.doi.org/10.1177/0269216316661685.

Full text
Abstract:
Background: Decisions about palliative systemic treatment are key elements of palliative and end-of-life care. Such decisions must often be made in complex, clinical situations. Aim: To explore the content of medical records of patients with advanced non-small cell lung cancer and pancreatic cancer with specific emphasis on doctors’ notes about decisions on palliative systemic treatment. Design: Medical record review (2009–2012) of 147 cancer patients containing 276 notes about palliative systemic treatment. We described the proportion of notes/medical records containing pre-specified items re
APA, Harvard, Vancouver, ISO, and other styles
41

Puckett, Lindsay, Lucille Lee, Petrina Zuvic, Isabella Bingchan Zhang, Louis Potters, and Beatrice Bloom. "Palliative treatment directives for bone metastases: A quality-directed approach to guiding institutional practice." Journal of Clinical Oncology 34, no. 26_suppl (2016): 188. http://dx.doi.org/10.1200/jco.2016.34.26_suppl.188.

Full text
Abstract:
188 Background: The efficacy of single fraction (fx) radiation treatment (RT) has proven to have equipoise for palliation of bone metastases when compared to courses of 10 fx or more. Despite these data, there has been a slow adoption of this practice in the US and worldwide. Examination of our multicenter practice from 2004 - 2016 showed that single fx RT utilization has remained at 17% and hypofractionationed (HFX) courses (1 or 5 fx) have remained at 71% since 2009. We hypothesized that evidence-based, treatment-guiding directives could improve HFX utilization in this population. Methods: I
APA, Harvard, Vancouver, ISO, and other styles
42

Novotný, Rudolf, Zuzana Novotná, and Štefánia Andraščíková. "Inappropriate hemodialysis treatment and palliative care." Ethics & Bioethics 10, no. 1-2 (2020): 48–58. http://dx.doi.org/10.2478/ebce-2020-0008.

Full text
Abstract:
AbstractThe paper discusses inappropriate (futile) treatment by analyzing the casuistics of palliative patients in the terminal stage of illness who are hospitalized at the Department of Internal Medicine and Geriatrics of the Faculty hospital with policlinic (FNsP). Our research applies the principles of palliative care in the context of bioethics. The existing clinical conditions of healthcare in Slovakia are characteristic of making a taboo of the issues of inappropriate treatment of palliative patients. Inductive-deductive and normative clinical bioethics methods of palliative care and eth
APA, Harvard, Vancouver, ISO, and other styles
43

Jafry, Baqir, Munir Buhaya, and Syed Mohammad Ali Kazmi. "Comparison of palliative treatment modalities among patients with colon cancer: A review of NCDB Database." Journal of Clinical Oncology 42, no. 3_suppl (2024): 220. http://dx.doi.org/10.1200/jco.2024.42.3_suppl.220.

Full text
Abstract:
220 Background: Among colon cancer patients some patients present with significant symptom burden needing upfront palliation-directed therapies, aimed to improve the quality of life of patients with severe illnesses. These include palliation-directed surgery, chemotherapy, radiation, pain management, or a combination of these. The extent to which these palliation-directed therapies are utilized in colon cancer remains under-explored. This study's purpose was to understand the trends in utilization and factors associated with palliation-directed treatment modalities among patients with colon ca
APA, Harvard, Vancouver, ISO, and other styles
44

ÖZTÜRK, Hüseyin Furkan, Gonca ALTINIŞIK İNAN, İpek Pınar ARAL, et al. "Clinical outcomes of palliative 3-dimensional conformal external beam gastric radiotherapy: single center experience." Journal of Medicine and Palliative Care 4, no. 1 (2023): 46–50. http://dx.doi.org/10.47582/jompac.1184122.

Full text
Abstract:
Aim: Patients diagnosed with locally advanced and/or metastatic gastric cancer and who cannot undergo surgery may need palliative treatment during their follow-up. There is scarce data about outcomes of palliative gastric radiotherapy (RT). In this study, we aimed to investigate the effect of 3-D external beam RT on oncological outcomes, as a non-invasive method.Material and Method: From 2013 to 2017, sixteen gastric cancer patients treated with palliative external RT in our institutional clinic were evaluated. Only patients who received palliative gastric radiotherapy for obstruction, pain an
APA, Harvard, Vancouver, ISO, and other styles
45

Ho, Samuel M. Y., and S. F. Leung. "Attitudes of Hong Kong Medical Students toward Different Modalities of Treatment for Cancer." Psychological Reports 76, no. 3_suppl (1995): 1291–96. http://dx.doi.org/10.2466/pr0.1995.76.3c.1291.

Full text
Abstract:
140 medical undergraduates in a Hong Kong medical school rated the usefulness of different modalities of cancer treatment for curative, medically palliative, and psychologically palliative care, respectively. Factor analyses showed that respondents used a Chinese versus non-Chinese cultural framework in conceptualizing modalities of treatment outside the conventional Western medical model. The functions of unconventional modalities were mainly for psychologically palliative care according to the respondents, although they did not regard these modalities as adversive to curative and medically p
APA, Harvard, Vancouver, ISO, and other styles
46

Chu, Wei-Min, Wen-Yu Kuo, and Yu-Chi Tung. "Effects of different palliative care models on decedents with kidney failure receiving maintenance dialysis: a nationwide population-based retrospective observational study in Taiwan." BMJ Open 13, no. 7 (2023): e069835. http://dx.doi.org/10.1136/bmjopen-2022-069835.

Full text
Abstract:
ObjectivesPatients with kidney failure receiving maintenance dialysis are a particularly important population and carry a heavy disease burden. However, evidence related to palliative care for patients with kidney failure receiving maintenance dialysis remains scarce, especially in regard to palliative care consultation services and palliative home care. This study aimed to evaluate the effects of different palliative care models on aggressive treatment among patients with kidney failure receiving maintenance dialysis during the end of life.DesignA population-based retrospective observational
APA, Harvard, Vancouver, ISO, and other styles
47

Dharmarajan, Kavita Vyas, Beryl McCormick, Chasity Walters, et al. "Use of a video decision tool to improve informed decision making in hospitalized patients considering palliative radiation therapy." Journal of Clinical Oncology 31, no. 31_suppl (2013): 29. http://dx.doi.org/10.1200/jco.2013.31.31_suppl.29.

Full text
Abstract:
29 Background: Substantial evidence exists to suggest improved patient outcomes when oncologic patients are involved in making treatment decisions. Tools have been shown to facilitate the decision-making process for patients, yet aids to support decision making in radiation therapy (RT) are scarce. Given RT is one of the more difficult modalities for patients to conceptualize, there is a pressing need to develop and test decision aids, particularly in patients with incurable cancers. Methods: In this study, a video decision tool was developed and tested with 42 inpatients referred for palliati
APA, Harvard, Vancouver, ISO, and other styles
48

Kucharska, Ewa, Aleksandra Kucharska, Aleksander Sieroń, Mariusz Nowakowski, and Karolina Sieroń. "MODERN METHODS OF TREATMENT IN PALLIATIVE CARE." Wiadomości Lekarskie 72, no. 7 (2019): 1229–35. http://dx.doi.org/10.36740/wlek201907101.

Full text
Abstract:
The palliative care patient is definitely a unique type of patient. Due to the complexity of the symptoms requires a holistic therapeutic approach. Modern methods of treatment in palliative and hospice care underline an important role of physio, kinesiotherapy and pharmacological treatment coexistence. The rehabilitation reduces clinical symptoms, accompanying the basic disease and increases the quality of life of palliative patients and their families. It becomes an inseparable element of treatment, both in outpatient care as well as in stationary care and home care. Due to the high dynamics
APA, Harvard, Vancouver, ISO, and other styles
49

Datta, Rupak, and Manisha Juthani-Mehta. "Burden and Management of Multidrug-Resistant Organisms in Palliative Care." Palliative Care: Research and Treatment 10 (January 1, 2017): 117822421774923. http://dx.doi.org/10.1177/1178224217749233.

Full text
Abstract:
Palliative care includes comprehensive strategies to optimize quality of life for patients and families confronting terminal illness. Infections are a common complication in terminal illness, and infections due to multidrug-resistant organisms (MDROs) are particularly challenging to manage in palliative care. Limited data suggest that palliative care patients often harbor MDRO. When MDROs are present, distinguishing colonization from infection is challenging due to cognitive impairment or metastatic disease limiting symptom assessment and the lack of common signs of infection. Multidrug-resist
APA, Harvard, Vancouver, ISO, and other styles
50

Thiong’o, Grace M., Susan S. Ferson, and A. Leland Albright. "Hydranencephaly treatments: retrospective case series and review of the literature." Journal of Neurosurgery: Pediatrics 26, no. 3 (2020): 228–31. http://dx.doi.org/10.3171/2020.3.peds19596.

Full text
Abstract:
OBJECTIVEThe objective of this study was to review treatment options for infants with hydranencephaly and to consider the pros and cons of each treatment modality.METHODSThis paper is a review of hydranencephaly as well as a retrospective analysis evaluating the outcomes of 52 infants with hydranencephaly who were treated at the Kijabe Hospital, Kijabe, Kenya, in one of four ways: ventriculoperitoneal shunt (VPS) insertion, endoscopic choroid plexus coagulation (CPC), open choroid plexectomy (CPlx), and palliative care. The primary outcome measure was control of head size, with the aim of impr
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!